A densely interconnected genome-wide network of micrornas and oncogenic pathways revealed using gene expression signatures

by Ooi, C.H., Oh, H.K., Wang, H.Z., Tan, A.L.K., Wu, J., Lee, M., Rha, S.Y., Chung, H.C., Virshup, D.M., Tan, P.
Published 2014

CD44-SLC1A2 gene fusions in gastric cancer

by Tao, J., Deng, N.T., Ramnarayanan, K., Huang, B., Oh, H.K., Leong, S.H., Lim, S.S., Tan, I.B., Ooi, C.H., Wu, J., Lee, M., Zhang, S., Rha, S.Y., Chung, H.C., Smoot, D.T., Ashktorab, H., Kon, O.L., Cacheux, V., Yap, C., Palanisamy, N., Tan, P.
Published 2014

Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)

by Yeo, W., Zee, B., Ma, B., Lam, K.C., Mo, F.K.F., Ng, E.K.W., Ho, R., Chan, A.T.C., Yeo, W., Boyer, M., Clarke, S., Beale, P., Chung, H.C., Roh, J.K., Rha, S.Y., Jeung, H.C., Ong, S.Y.K., Lim, R., Soo, R., Goh, B.C.
Published 2011

Oncogenic pathway combinations predict clinical prognosis in gastric cancer

by Ooi, C.H., Tan, P., Ivanova, T., Wu, J., Lee, M., Tao, J., Koo, J.H., Gopalakrishnan, V., Zhu, Y., Lee, J., Ganesan, K., Tan, I.B., Tao, J., Ward, L., Grabsch, H., Cheng, L.L., Rha, S.Y., Chung, H.C., So, J., Soo, K.C., Lim, D., Chan, W.H., Wong, W.K., Bowtell, D., Boussioutas, A., Yeoh, K.G.
Published 2011

Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors fr...

by Yeo, W., Chung, H.C., Chan, S.L., Wang, L.Z., Lim, R., Picus, J., Boyer, M., Mo, F.K.F., Koh, J., Rha, S.Y., Hui, E.P., Jeung, H.C., Roh, J.K., Yu, S.C.H., To, K.F., Tao, Q., Ma, B.B., Chan, A.W.H., Tong, J.H.M., Erlichman, C., Chan, A.T.C., Goh, B.C.
Published 2014